Edible Garden AG Incorporated reported first-quarter 2026 revenue of $3.3 million, up from $2.7 million a year earlier, driven mainly by strong growth in cut herb sales across its retail customer base.
Operating expenses rose sharply to $10.0 million from $5.6 million, largely due to higher cost of goods sold and about $2.7 million of depreciation and amortization, including accelerated depreciation tied to the company’s pivot toward ready-to-drink clean nutrition manufacturing at its Prairie Hills facility. The company recorded an income tax benefit of $3.4 million from selling New Jersey net operating losses, reducing its net loss to $3.7 million versus $3.3 million in the prior-year quarter.
Cash was $2.0 million as of March 31, 2026, with total assets of $17.5 million and total debt of $2.7 million. Management continues to warn of substantial doubt about its ability to continue as a going concern and expects to require additional financing to fund operations beyond the near term.
Edible Garden AG reported strong top-line growth but wider operating losses for the three months ended March 31, 2026. Revenue rose 22.9% to about $3.3 million from $2.7 million, driven by roughly 46% growth in cut herb sales and expansion across vitamins, supplements, condiments, and international markets.
Total operating expenses increased to about $10.0 million from $5.6 million, mainly from higher cost of goods sold due to a sales mix shift toward third‑party sourced cut herbs and a sharp rise in depreciation tied to the company’s pivot into ready‑to‑drink (RTD) clean nutrition manufacturing. The company recorded an income tax benefit of roughly $3.4 million from selling New Jersey state tax benefits, which helped limit the net loss to about $3.7 million, compared with a $3.3 million loss a year earlier.
Management highlighted continued retail expansion to more than 6,000 locations and progress integrating Tetra Pak processing for shelf‑stable RTD products, positioning the business as a broader clean‑label nutrition platform despite current losses.
Edible Garden AG Incorporated filed Amendment No. 1 to its 2025 annual report to add Part III information on directors, executive compensation, ownership, related-party transactions, and auditor fees. The amendment does not change or update the financial statements in the original filing.
The company reports aggregate market value of non‑affiliate equity of about $7.7 million as of June 30, 2025 and 5,213,691 common shares outstanding as of April 27, 2026. CEO James Kras received $2,919,365 in 2025 compensation, driven by salary, a $500,000 transaction bonus and $2.0 million in equity awards under a new employment agreement with significant severance and change‑in‑control protections.
The filing outlines a 2025 officer and director equity plan with up to 777,862 shares available, director stock awards, and detailed board committee structures. It also highlights extensive related‑party financing with Streeterville Capital and affiliates, including $3.5 million of Series B Preferred Stock issuance, promissory notes, and a favorable Iowa facility lease, as well as 2025 audit and other fees of $451.9 thousand.
Edible Garden AG Incorporated reported an unregistered exchange of preferred stock into common shares. On April 21, 2026, the company entered into exchange agreements with Streeterville Capital, LLC to swap 3,301 shares of Series B Preferred Stock for 3,587,478 shares of common stock.
The Series B Preferred Stock had an aggregate stated value of $3,301,000, or $1,000 per share. The number of common shares issued was calculated by dividing this stated value by the Nasdaq Minimum Price of the company’s common stock on the trading day immediately before the agreements. The exchange was conducted under the Section 3(a)(9) exemption and the shares were not registered under the Securities Act of 1933.
Edible Garden AG Incorporated reported that it entered into exchange agreements with Streeterville Capital, LLC on March 26, 2026 and April 15, 2026. The Company exchanged 135 shares of its Series B Preferred Stock, with an aggregate stated value of $135,000, for a total of 128,119 shares of common stock. The number of common shares issued was calculated by dividing the stated value by the Nasdaq Minimum Price of the Company’s common stock on the trading day before each agreement date. These common shares were issued as unregistered securities under Section 3(a)(9) of the Securities Act.
Edible Garden AG Incorporated outlines a year of strategic expansion alongside significant financial strain. The controlled environment agriculture company reported net losses of approximately $17.3 million in 2025 and $11.1 million in 2024, and its auditors expressed substantial doubt about its ability to continue as a going concern.
The business is evolving beyond fresh herbs into higher-margin, shelf-stable nutrition and ready-to-drink beverages. A 200,000-square-foot Iowa facility is being transformed into an aseptic RTD manufacturing hub under interim agreements with Tetra Pak, with first-phase production anticipated in 2027, subject to a final supply agreement, capital, and approvals.
Growth initiatives also include acquiring a five-acre Michigan greenhouse and $12.0 million of aquaculture assets with patented water-treatment technology, expanding its Zero-Waste Inspired platform. However, the company remains dependent on external financing, faces intense competition, weather and cost pressures, and relies heavily on a small group of grocery customers that accounted for 88.2% of 2025 revenue.
Edible Garden reported 2025 results showing weaker profitability while accelerating a shift into higher-margin, shelf-stable and ready-to-drink (RTD) nutrition products. Full-year revenue was approximately $12.8 million, down from $13.9 million in 2024, as the company exited lower-margin produce lines.
Full-year gross profit declined to about $(0.2) million from $2.3 million, with gross margin falling to (1.6)% from 16.7%, largely due to elevated fourth-quarter procurement and logistics costs. Selling, general and administrative expenses rose to roughly $15.6 million from $11.6 million, reflecting investments in personnel, infrastructure, and acquisitions.
Operationally, cut herbs unit sales grew about 22.9% year-over-year and vitamin and supplement unit sales rose roughly 47.7%, including approximately 78.6% growth in international vitamin and supplement revenue. The company expanded to nearly 6,000 store locations and is developing an RTD manufacturing hub in the Midwest, supported by planned Tetra Pak processing integration.
Edible Garden AG Incorporated entered into exchange agreements with Streeterville Capital on March 19, 24, and 26, 2026. The company exchanged 55, 1,054, and 75 shares of its Series B Preferred Stock, respectively, for a total of 670,199 shares of common stock.
The Series B Preferred Stock had an aggregate stated value of $1,184,000, or $1,000 per share. The number of common shares issued was calculated by dividing this stated value by the Nasdaq Minimum Price of the common stock on the trading day before each agreement date. The exchanges were unregistered transactions relying on the Section 3(a)(9) exemption under the Securities Act.
Edible Garden AG Incorporated reported an unregistered equity transaction involving its Series B preferred stock. On March 12, 2026, the company agreed with Streeterville Capital, LLC to exchange 121 shares of Series B Preferred Stock, with an aggregate stated value of $121,000, for 50,840 shares of common stock.
The exchange ratio was calculated by dividing the stated value by the Nasdaq Minimum Price of the company’s common stock on the trading day immediately before the agreements were signed. The common shares were issued under the Securities Act Section 3(a)(9) exemption and were not registered.
Edible Garden AG Incorporated reported that it entered into a series of exchange agreements with Streeterville Capital, LLC on February 9, March 4, March 9 and March 10, 2026. Under these agreements, the company exchanged 90, 192, 65 and 133 shares of its Series B Preferred Stock, with an aggregate stated value of $480,000, for a total of 175,165 shares of common stock.
The number of common shares issued was calculated by dividing the stated value of the preferred stock, set at $1,000 per share, by the Nasdaq Minimum Price of the company’s common stock on the trading day immediately before each agreement date. These common shares were issued without registration under the Securities Act, relying on the Section 3(a)(9) exemption for exchanges with an existing security holder.